Diversified Enterprises’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$424K Buy
11,018
+88
+0.8% +$3.63K 0.02% 267
2025
Q4
$450K Buy
10,930
+87
+0.8% +$3.44K 0.03% 231
2025
Q3
$404K Sell
10,843
-1,138
-9% -$41.4K 0.03% 190
2025
Q2
$437K Buy
11,981
+103
+0.9% +$3.73K 0.03% 178
2025
Q1
$459K Sell
11,878
-76
-0.6% -$3.01K 0.04% 170
2024
Q4
$453K Buy
11,954
+80
+0.7% +$3.19K 0.04% 141
2024
Q3
$498K Buy
+11,874
New +$493K 0.05% 123

Other funds holding BME

Diversified Enterprises's BME Position: Q1 2026 in Review

Diversified Enterprises increased its BlackRock Health Sciences Trust (BME) stake by 0.81% in Q1 2026, buying an estimated $3.63K and bringing the position to 11,018 shares worth $424K. The position accounts for 0.02% of the portfolio, ranked #267.

Diversified Enterprises first reported a position in BME in Q3 2024 and has held it in 7 quarters since. The position peaked at $498K in Q3 2024. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • Diversified Enterprises held 11,018 shares of BlackRock Health Sciences Trust worth $424K as of Q1 2026.
  • Diversified Enterprises bought 88 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $3.63K.
  • BlackRock Health Sciences Trust made up 0.02% of Diversified Enterprises's portfolio in Q1 2026, its #267 holding.
  • Diversified Enterprises first reported a position in BlackRock Health Sciences Trust in Q3 2024 and has held it in 7 quarters since.
  • Diversified Enterprises's BlackRock Health Sciences Trust position peaked at $498K in Q3 2024.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Diversified Enterprises's 13F filing for Q1 2026, filed 15 May 2026.